Anita Desai Selected Research

Neuroblastoma

4/2020	Prohibitin 1/2 mediates Dengue-3 entry into human neuroblastoma (SH-SY5Y) and microglia (CHME-3) cells.
3/2009	Heat shock protein 70 on Neuro2a cells is a putative receptor for Japanese encephalitis virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anita Desai Research Topics

Disease

15	Infections 12/2021 - 02/2007
5	Rabies (Hydrophobia) 07/2014 - 05/2006
3	Dengue (Dengue Fever) 01/2017 - 10/2002
3	HIV Infections (HIV Infection) 10/2011 - 12/2006
2	Scrub Typhus (Typhus, Scrub) 01/2022 - 07/2019
2	Acute Febrile Encephalopathy 01/2022 - 11/2010
2	Neuroblastoma 04/2020 - 03/2009
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2018 - 12/2013
2	Chikungunya Fever 08/2014 - 11/2012
2	Disease Progression 10/2011 - 12/2006
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2008 - 10/2006
1	Fever (Fevers) 01/2022
1	COVID-19 07/2021
1	Inflammation (Inflammations) 01/2017
1	Human Influenza (Influenza) 01/2017
1	Tuberculosis (Tuberculoses) 01/2011
1	Meningitis 11/2010
1	Encephalitis (Encephalitis, Rasmussen) 11/2010
1	Japanese Encephalitis 07/2010
1	Atrophy 04/2009
1	Body Weight (Weight, Body) 02/2009
1	Opportunistic Infections (Opportunistic Infection) 01/2009
1	Dementia (Dementias) 01/2009
1	Virus Diseases (Viral Diseases) 05/2008
1	Leukemia 05/2008
1	Neoplasms (Cancer) 02/2007

Drug/Important Bio-Agent (IBA)

8	Immunoglobulin M (IgM)IBA 01/2022 - 10/2002
4	AntibodiesIBA 12/2021 - 10/2002
3	Immunoglobulin G (IgG)IBA 12/2021 - 10/2002
3	CytokinesIBA 01/2018 - 08/2014
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2009
2	Pattern Recognition ReceptorsIBA 01/2018 - 12/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 08/2014
2	ChemokinesIBA 01/2017 - 08/2014
2	Biomarkers (Surrogate Marker)IBA 08/2014 - 12/2006
2	NucleotidesIBA 08/2011 - 06/2008
2	EnzymesIBA 11/2010 - 12/2009
2	ImmunosorbentsIBA 11/2010 - 12/2009
2	Pharmaceutical PreparationsIBA 11/2008 - 10/2006
1	Small Interfering RNA (siRNA)IBA 04/2020
1	ProhibitinsIBA 04/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Attenuated VaccinesIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017
1	QuercetinIBA 01/2017
1	EpitopesIBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 08/2014
1	Myeloid Differentiation Factor 88IBA 07/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2014
1	Glycoproteins (Glycoprotein)IBA 07/2014
1	NucleoproteinsIBA 05/2013
1	Indicators and Reagents (Reagents)IBA 10/2011
1	HLA-B57 antigenIBA 01/2011
1	HLA-A Antigens (HLA-A)IBA 01/2011
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 03/2009
1	X 50IBA 02/2009
1	Pentoxifylline (Trental)FDA LinkGeneric 02/2009
1	RNA (Ribonucleic Acid)IBA 01/2009
1	N-methylisatinIBA 05/2008
1	ThiosemicarbazonesIBA 05/2008
1	Antiviral Agents (Antivirals)IBA 05/2008
1	Therapeutic UsesIBA 05/2008
1	IsatinIBA 05/2008
1	Transcription Factors (Transcription Factor)IBA 10/2007
1	Biological ProductsIBA 02/2007
1	IsoenzymesIBA 02/2007
1	Adenosine DeaminaseIBA 02/2007
1	SYBR Green IIBA 05/2006
1	Viral AntigensIBA 10/2002

Therapy/Procedure

3	Highly Active Antiretroviral Therapy (HAART) 04/2009 - 12/2006
2	Therapeutics 10/2011 - 02/2007